Patent · US Expired

Viral interleukin-6

US7968696B1 · kind B1 · utility

0Cited by

3References

6Claims

0Family size

Assignees

Behring Diagnostics GmbH · DE
NEW YORK UNIVERSITY · US

Inventors

Bernhard Fleckenstein · Wiesenthau, DE
Jens-Christian Albrecht · Ergolding, DE
Frank Neipel · Erlangen, DE
Alvin Friedman-Kien · New York, US
Yao-Qi Huang · New York, US

Key dates

Filing date	Jul 19, 1996
Grant date	Jun 28, 2011
Priority date	—
Expiry date	Mar 2, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16622
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.